Oxford Catalysts Group PLC
22 January 2007
Oxford Catalysts Group plc (the 'Company')
Disclosure of material interest in shares
IP Group announces that IP2IPO Limited transferred 150,000 ordinary shares of 1p
each in the Company (representing 0.4%) on 18 January 2007, held for the benefit
of David Norwood, to the Michael Norwood Memorial Trust ('the Trust') for nil
consideration. David Norwood is not a beneficiary of the Trust and the Trust has
entered into a lock in agreement which is subject to the same terms and
conditions as the lock in agreement entered into by IP2IPO Limited on flotation
of the Company.
Following this transaction, IP2IPO Limited has a registered interest in
10,706,061 ordinary shares of 1p each ('Ordinary Shares'), representing 28.67%
of the Company's issued share capital of which 1,786,829 Ordinary Shares (4.79%)
are held for the benefit of certain employees of IP2IPO Limited.
Enquiries:
Alan Aubrey
020 7489 5200
22 January 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.